Company Corbus Pharmaceuticals Holdings, Inc.
Equities
CRBP
US21833P3010
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.8 USD | +3.13% | -4.93% | +608.61% |
Business Summary
Number of employees: 19
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yuval Cohen
CEO | Chief Executive Officer | 49 | 13-06-30 |
Sean Moran
DFI | Director of Finance/CFO | 66 | 14-04-10 |
Chief Tech/Sci/R&D Officer | 50 | Feb. 27 | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Holmer
CHM | Chairman | 74 | 13-12-31 |
Avery Catlin
BRD | Director/Board Member | 75 | 14-07-31 |
Yuval Cohen
CEO | Chief Executive Officer | 49 | 13-06-30 |
John Jenkins
BRD | Director/Board Member | 66 | 18-06-04 |
Jacques Suzanne
BRD | Director/Board Member | 53 | 19-04-07 |
Yong Ben
BRD | Director/Board Member | 50 | 23-02-28 |
Peter Salzmann
BRD | Director/Board Member | 56 | 20-03-05 |
Anne Altmeyer
BRD | Director/Board Member | 59 | 22-09-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,686,693 | 10,613,932 ( 99.32 %) | 0 | 99.32 % |
Company contact information
Corbus Pharmaceuticals Holdings, Inc.
500 River Ridge Drive Second floor
02062, Norwood
+617 963 0100
http://www.corbuspharma.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+608.61% | 457M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- CRBP Stock
- Company Corbus Pharmaceuticals Holdings, Inc.